MAKO incorporated in Delaware in November 2004.
MAKO is headquartered at:
2555 Davie Road,
Ft. Lauderdale,
Florida 33317.
MAKO is a medical device company that markets its advanced robotic arm solution and implants for minimally invasive orthopedic knee procedures.
MAKO employed 130 people as of February 13, 2008.
MAKO Surgical stock is traded on the NASDAQ Global Market under the ticker symbol MAKO.
MAKO shares can be purchased or sold by working with a registered broker.
For stockholder inquiries, please contact our transfer agent and registrar:
BNY Mellon Shareowner Services
300 Galleria Parkway, Suite 1020
Atlanta, GA 30339
(770) __________________
MAKO does not currently pay a dividend on its shares.
You can contact MAKO Investor Relations by calling 954.927.2044 or 410.321.9651 or by email at
investorrelations@makosurgical.com or
mark.klausner@westwickepartners.com
December 31st is the fiscal year end.
A list of
analysts that report on MAKO is available in the Stock Information section of this site. To obtain a copy of a report, you must contact the analyst directly.
Ernst & Young LLP in Ft. Lauderdale, Florida is our independent registered public accounting firm.
Please submit your question using the form below. * Required fields